Form 4: Ekso Bionics CEO Acquires Shares Through 401(k) Contribution
SEC Form 4 Filing
CEO Scott G. Davis acquired 5,590 shares of Ekso Bionics through the company's 401(k) contribution matching program.
Summary
- On March 14, 2025, Scott G. Davis, CEO of Ekso Bionics Holdings, Inc., acquired 5,590 shares of common stock.
- The acquisition was made through the Issuer's 401(k) contribution matching program.
- Following the transaction, Davis directly owns 331,372 shares of common stock and indirectly owns 5,590 shares through his 401(k).
Sentiment
Score: 6
Explanation: The document is neutral, simply reporting a transaction. The CEO's participation in the 401k program is a mildly positive signal.
Positives
- The CEO's participation in the 401(k) program and subsequent share acquisition could be seen as a positive sign of confidence in the company's future.
Industry Context
This filing is a routine disclosure related to executive compensation and benefits, and doesn't necessarily reflect broader industry trends.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals confidence from the CEO.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of the transaction where Scott G. Davis acquired shares. |
| 03/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.